TechConnect Innovation Program

Pharmaceutical composition and pharmacological treatment for enhancement of methadone analgesia and prevention of methadone tolerance.

Biotechnology Institute, National University of La Rioja, La Rioja, Argentina

TECHNOLOGY SUMMARY

We developed an innovative pharmaceutical composition for the treatment of pain, which can be formulated as soft capsules. The promising pharmacological treatment associated with its use would solve some of the serious problems of using methadone allowing the use of lower doses to achieve the same pharmacodynamic effect.

Primary Application Area: Pharmaceuticals & Personal Care

Technology Development Status: Proven Manufacturability

Technology Readiness Level: TRL 3

FIGURES OF MERIT

Value Proposition: This pharmaceutical formulation (whose main component is methadone) and the associated pharmacological treatment will catch the pharmaceutical industry’s attention as it offers two advantages: it enhances methadone effect which makes it possible to use lower doses and consequently reduces its side effects. It also decreases the methadone analgesic tolerance effect.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Global Innovation Awardee

Showcase Booth #: 723

Website: www.unlar.edu.ar (rector@unlar.edu.ar) www.fcq.unc.edu.ar

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: University of La Rioja in a partnership program with University of Córdoba

Primary Sources of Funding: University

Looking for: Both Funding and Development Partners